Thermo Fisher targets $255B science market

Thermo Fisher Scientific used its May 20 investor day to make a broader argument than a standard growth update. The company said it now serves an addressable science market of $255 billion, up from the $235 billion market it cited at its 2024 investor day, and tied that opportunity to stronger use of AI across research, drug discovery and laboratory workflows. Marc Casper, Thermo Fisher’s chairman and chief executive, said customers value the company as a “trusted partner” and that its “scale and depth of capabilities” position it well in “an increasingly AI-enabled world.” The company also reiterated long-term targets of 7% organic revenue compound annual growth and low-teens adjusted earnings-per-share growth. (businesswire.com) ### Why did Thermo Fisher spend investor day talking about market size? Thermo Fisher said the $255 billion figure reflects “attractive end markets” with improving demand trends and long-term growth fundamentals. The company presented that market framing alongside its usual case for share gains: innovation, customer relationships, commercial reach and its Practical Process Improvement, or PPI, business system. (businesswire.com) The comparison with September 2024 is notable because Thermo Fisher then described its market as $235 billion with long-term market growth of 4% to 6%. The new figure suggests the company is broadening or updating the opportunity set it wants investors to focus on. That is an inference based on the company’s two investor-day presentations. (businesswire.com) ### What did the company actually say about AI? Casper’s prepared remarks did not give a standalone revenue target for AI products or services. Instead, Thermo Fisher folded AI into a larger pitch about scientific productivity, customer workflows and the advantage of combining instruments, services and software at scale. (businesswire.com) Thermo Fisher’s investor relations materials also describe the company as the world leader in serving science, with annual revenue over $45 billion. That scale matters because the company already spans analytical instruments, specialty diagnostics, life sciences solutions and laboratory services, giving it multiple points of contact inside customer workflows. (businesswire.com) ### Why do the long-term targets matter? The 7% organic revenue CAGR and low-teens adjusted EPS growth targets tell investors Thermo Fisher is keeping the same broad financial ambition even as it updates the market narrative around AI and workflow depth. The company said disciplined capital deployment and execution through PPI remain central to that plan. (ir.thermofisher.com) April 23 results provide the latest near-term baseline. Thermo Fisher reported first-quarter 2026 revenue of $11.01 billion, up 6%, and adjusted EPS of $5.44, up 6%, for the quarter ended March 28. ### What does this say about how Thermo Fisher wants to compete? Thermo Fisher’s own language points to a strategy built around integrated capabilities rather than single product categories. (businesswire.com) The company said its “combined capabilities” help customers succeed and described its commercial engine as a competitive advantage created by deep customer engagement. (ir.thermofisher.com) That matters because the company has continued to add assets around the core franchise. In March, Thermo Fisher completed its acquisition of Clario Holdings, and in April it said it had agreed to sell its microbiology business to Astorg. Those moves show active portfolio management around higher-priority businesses. ### What should investors watch next? (businesswire.com) Thermo Fisher said on April 28 that the May 20 event in New York would include presentations from senior management and a Q&A session, and that a replay would be posted afterward. Investors looking for more detail on the $255 billion market, AI initiatives and segment assumptions will likely focus on that webcast and future quarterly filings. (newsroom.thermofisher.com) The next hard data point will come with Thermo Fisher’s second-quarter 2026 results, following first-quarter revenue of $11.01 billion and the company’s reaffirmed long-term framework. (ir.thermofisher.com 1) (ir.thermofisher.com 2)